GAIN THERAPEUTICS, INC Public Float
GAIN THERAPEUTICS, INC (GANX) had Public Float of $53.20 million as of 2025-06-30, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-26
- 2025-06-30: Entity Public Float $53.20M.
- 2024-06-30: Entity Public Float $30.80M.
- 2023-06-30: Entity Public Float $56.60M.
- 2022-06-30: Entity Public Float $38.80M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $53.20M 10-K · filed 2026-03-26 |
| 2024-06-30 | $30.80M 10-K · filed 2025-03-27 |
| 2023-06-30 | $56.60M 10-K · filed 2024-03-26 |
| 2022-06-30 | $38.80M 10-K · filed 2023-03-23 |
| 2021-06-30 | $118.70M 10-K/A · filed 2022-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |